Intellia Therapeutics, Inc. (NASDAQ:NTLA) has released positive new clinical data from the ongoing phase 1 trial of Nexiguran Ziclumeran (Nex-Z), also known as NTLA-2001, in patients with ...

Cytokinetics sank -8.2% this morning, compared to the S&P 500's day change of -1.0%. Today's losers may turn out to be ...

The system will be deployed as part of the initial rollout on the fleet of one of its leading U.S customers, with implementation starting by the ...

Tisaranee Gunasekara’s usually excellent writings are informed by a strong moral compass. In her recent examination of the ...

Investors exercised all Warrants from the private placement closed in October 2023, along with warrants held by Beyond Oil’s Canadian strategic partner, West Coast Reduction Ltd., from a private ...

EASA's stamp of approval strengthens ParaZero's technology as a trusted solution for drone operations throughout Europe, ensuring safer, more versatile missions for commercial operators.

The wait is over! The UK Supreme Court has handed down its judgment in the closely followed and long-running litigation between Sky, the ...

However, it is safe to infer that Hondas solid electrolytes will almost certainly ... this polymer barrier prevents any ...

But romance isn’t just for the starry-eyed. It’s perfectly attainable if we take a moment to consider just how much we get in ...

ParaZero's SafeAir M-300/ M-350 Pro parachute systems comply with key safety requirements, enabling drone operators to enhance their operational scope Tel Aviv, Israel, Nov. 18, 2024 (GLOBE NEWSWIRE) ...

Goods not liable for seizure and penalty thereof when designated route not taken during transportation ...

IBM will incorporate its Spyre Accelerator in future Power products—including its Power11 system releasing next year—and ...